Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers.
about
Can nanomedicines kill cancer stem cells?Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemiaDrug Carriers: Not an Innocent Delivery ManUltrasound-induced new cellular mechanism involved in drug resistance.Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking.Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers.Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance.Endocytosis of nanomedicines.Pluronics and MDR reversal: an update.Synthetic and natural polyanions induce cytochrome c release from mitochondria in vitro and in situ.Pluronic F127 polymeric micelles for co-delivery of paclitaxel and lapatinib against metastatic breast cancer: preparation, optimization and in vitro evaluation.Structural parameters governing activity of Pluronic triblock copolymers in hyperthermia cancer therapyA one-step electrospray-based technique for modulating morphology and surface properties of poly(lactide-co-glycolide) microparticles using Pluronics®.A simple way to enhance Doxil® therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer.Synthesis of bisethylnorspermine lipid prodrug as gene delivery vector targeting polyamine metabolism in breast cancer.Synergistic effects of A-B-C-type amphiphilic copolymer on reversal of drug resistance in MCF-7/ADR breast carcinoma.Preparation and antitumor evaluation of self-assembling oleanolic acid-loaded Pluronic P105/d-α-tocopheryl polyethylene glycol succinate mixed micelles for non-small-cell lung cancer treatment.pH-sensitive micelles for the intracellular co-delivery of curcumin and Pluronic L61 unimers for synergistic reversal effect of multidrug resistance.Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.Possibilities to increase the effectiveness of doxorubicin in cancer cells killing.Recent advances in delivery of drug-nucleic acid combinations for cancer treatmentPolymeric micelles for oral drug administration enabling locoregional and systemic treatments.Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer.Hurdles in selection process of nanodelivery systems for multidrug-resistant cancer.Examination of Gossypol-Pluronic Micelles as Potential Radiosensitizers.Precious metal carborane polymer nanoparticles: characterisation of micellar formulations and anticancer activity.Suppression of cancer-initiating cells and selection of adipose-derived stem cells cultured on biomaterials having specific nanosegments.The exposure of cancer cells to hyperthermia, iron oxide nanoparticles, and mitomycin C influences membrane multidrug resistance protein expression levels.The influence of Pluronics® on dark cytotoxicity, photocytotoxicity, localization and uptake of curcumin in cancer cells: studies of curcumin and curcuminoids XLIX.Effects of surfactants on the properties of PLGA nanoparticles.Relationship between the affinity of PEO-PPO-PEO block copolymers for biological membranes and their cellular effects.pH-and thermo-sensitive pluronic/poly(acrylic acid) in situ hydrogels for sustained release of an anticancer drug.Effect of poly (ethylene oxide)-poly (propylene oxide)-poly (ethylene oxide) micelles on pharmacokinetics and intestinal toxicity of irinotecan hydrochloride: potential involvement of breast cancer resistance protein (ABCG2).Berberine Enhances Chemosensitivity and Induces Apoptosis Through Dose-orchestrated AMPK Signaling in Breast Cancer.Inhibition of P-glycoprotein pumps by PEO-PPO amphiphiles: branched versus linear derivatives.Drug resistance reversal by combretastatin-A4 phosphate loaded with doxorubicin in polymersomes independent of angiogenesis effect.Injectable (-)-gossypol-loaded Pluronic P85 micelles for cancer chemoradiotherapy.AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells.Mixed Micelles for Targeted and Efficient Doxorubicin Delivery to Multidrug-Resistant Breast Cancer Cells.Pluronic® block-copolymers in medicine: from chemical and biological versatility to rationalisation and clinical advances
P2860
Q27022017-29925FD3-BCDD-4CA4-9CC2-0FDD1E5255F3Q27309004-21999BB1-8C1A-4179-9417-EB93B014BE68Q28082414-7C314930-C769-41D2-923F-2DBE5D355C06Q28484442-2831D9E2-1DB1-4445-BFE9-DD73FE92DD85Q30472420-EE2E84EE-B056-4C57-AEB3-D695E40096F8Q30475533-776BE973-AD8A-4F70-AEEE-B141E1C48D35Q33763765-8A47B31F-7D86-40D7-9B23-CA343E9CADB6Q33987301-084238B1-E29A-41A8-A07A-7FCF3328CE14Q34005678-B26B0AEE-B73B-421A-842B-D1F1FE2828C1Q34979266-E83FA5D0-AD08-4ECC-A520-6EC1B6027E61Q35284749-58FE1408-019B-47D1-8AA4-5C3C0D2AE815Q35800826-228942C9-A19E-4080-B438-A77461B5B6E6Q36294987-6FD7AB26-E70C-4F69-866C-0799570A771FQ36867763-F4B19EFF-D515-482A-8DB1-44F5FC0EB126Q37243049-B1FCAB3A-2F19-4BA5-AF71-36E8CB30E38DQ37344258-040DFACC-6830-47FA-BD96-54D2CACFC537Q37469246-AE298FCA-4000-4C35-B5B4-751670918DCCQ37640892-9008E3CA-96DC-4B6F-8BC4-359E5ACEA44CQ37763152-61995C55-DB71-4160-B595-2CEF9DE91A43Q37937579-8E87DBA8-914B-47D4-8C51-BCABF09113ECQ38102522-261A9BE9-7FBF-48BB-8D19-E74AFEFB6D23Q38250152-A7A32681-569D-4228-9A6E-4E476B81F2F2Q38813380-77812604-5B7D-484D-B18D-EA0F4BA6B2A1Q38818166-C8B2A91B-B99B-4F77-A689-4FFBBA909D67Q38846041-1D46911A-1D76-4439-8C4A-A6CA70A5A7ADQ38951818-6F5B77F1-0CC3-44C7-A7C3-4622ED2D913FQ39095597-DD81B1AC-4670-4127-94FF-07BC068E5563Q39200057-767A0CEB-8F9D-4B51-907C-2675E0FB4FEDQ39251867-68F770C2-D244-44D5-A17A-8FC52AF40725Q39352101-4B81BC80-F2F4-4807-A782-1E37F24C7B09Q39384996-79AD6C8B-C697-4863-9CA9-662B4BCC756CQ39547558-49F109CE-5FE1-4E32-ABB6-3AF4DC40818FQ39675232-4BA582BE-E604-4723-898A-8EB735F7BAA1Q41180271-A75F8182-C83E-4C7A-870E-8220A1855C51Q42786611-7CD6CFEC-B018-47B7-B79C-DEE57589EA11Q46380343-79BA1980-8E07-4DB5-A1C5-12E2D8DA58FFQ48939497-D2096280-4B11-4FD0-A8D0-A7C6274EA45FQ52581254-E87365FD-AC06-4BCE-91DA-ED889F6C9B71Q53800236-24DF207B-4526-4081-9E12-F94A230416F0Q57376795-194A8C45-A4E3-4CBE-857D-19AA88E7E43A
P2860
Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Differential metabolic respons ...... ion of drug resistant cancers.
@en
Differential metabolic respons ...... ion of drug resistant cancers.
@nl
type
label
Differential metabolic respons ...... ion of drug resistant cancers.
@en
Differential metabolic respons ...... ion of drug resistant cancers.
@nl
prefLabel
Differential metabolic respons ...... ion of drug resistant cancers.
@en
Differential metabolic respons ...... ion of drug resistant cancers.
@nl
P2093
P2860
P1476
Differential metabolic respons ...... tion of drug resistant cancers
@en
P2093
Alexander A Timoshin
Daria Yu Alakhova
David Nicholls
Elena V Batrakova
Nataliya Y Rapoport
Valery Yu Alakhov
P2860
P304
P356
10.1016/J.JCONREL.2009.09.026
P407
P50
P577
2009-10-06T00:00:00Z